PRESS-RELEASE ·Filed Apr 22, 2026
Press release · Earnings
Final — all horizons settled through T+60d
RXST ▼ -22.08% at T+60d
NEUTRAL call -22.08% · α vs SPY -27.10% · entry $7.20 → $5.61
T+1d
+0.69%
call +0.69% · α -0.09%
$7.25
settled 6mo ago
T+5d
-5.42%
call -5.42% · α -6.89%
$6.81
settled 6mo ago
T+20d
-14.44%
call -14.44% · α -19.08%
$6.16
settled 5mo ago
T+60d
-22.08%
call -22.08% · α -27.10%
$5.61
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
RxSight, Inc. announced it will report its Q1 2026 results on May 6.
Key Facts
- RxSight, Inc. announced it will report its Q1 2026 results on May 6.
Market Snapshot
Exchange
Nasdaq
Sector
Ophthalmic Goods
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3279393 |
5 reports for RXST
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | Press Release | $4.90 | awaiting T+20 | — | $4.93 (+0.61%) |
Sep 2, 2026 7w ago | Insider Cluster | $6.54 $4.68 | ▲ +28.44% | ▲ +27.25% | $4.93 (+24.62%) |
Sep 2, 2026 7w ago | Insider Cluster | $6.54 $4.68 | ▼ −28.44% | ▼ −27.25% | $4.93 (−24.62%) |
Apr 22, 2026 26w ago | Press Release | $7.20 $6.16 | ▼ −14.44% | ▼ −19.08% | $4.93 (−31.53%) |
Feb 27, 2026 34w ago | EFFECT | $7.48 $6.26 | ▼ −16.31% | ▼ −8.75% | $4.93 (−34.09%) |
Showing 5 of 5
US Market Status
Market Closed — Opens in 1h 12m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers